title: Polymorphic variation in the G-protein beta-3 subunit gene and response to BiDil in A-HeFT: Basis for an African-American pharmacogenetic advantage to nitric oxide donor therapy?
authors.affiliation: Division of Cardiology and Cardiovascular Institute, University of Colorado, Aurora, Colorado. Electronic address: michael.bristow@ucdenver.edu.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Bristow
mesh_terms: D005260:Female; D006333:Heart Failure / Q000235:genetics*; D020962:Heterotrimeric GTP-Binding Proteins / Q000235:genetics*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D006830:Hydralazine; D020962:Heterotrimeric GTP-Binding Proteins; D007548:Isosorbide Dinitrate
keywords: heart failure; outcomes; pharmacogenetics; race